News
News
Top 10 at 10: Legal mushrooms? The party is at Bioxyne’s house
News
ASX Health Stocks: Althea strikes deal in Canada, will make 40pc of all cannabis-infused drinks in the country
News
Market Highlights: Meta surges 14pc, uranium stocks most traded by Aussies, and 5 small caps to watch today
Health & Biotech
ASX Health Stocks: Singular Health shoots 60pc through the roof after breakthrough deal in US
News
Market Highlights: ASX to track Wall Street’s sharp selloff after Powell comments; and 5 small caps to watch
News
In Case You Missed It: Key approvals for resource plays and Aroa looks to improve mastectomy surgery
Health & Biotech
Neurotech gets green light to start phase I/II cerebral palsy trial
Health & Biotech
Bioxyne’s Q2 FY24 revenue surpasses $2.5m on Aussie medicinal cannabis growth
Experts
CRITERION: Uranium’s got that healthy glow… but here’s why you need to handle it with care
Health & Biotech
Weed Week: Medicinal cannabis will be here no matter what; and recent ASX pot winners
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Healthy balance sheet with no debt, this overlooked ASX health stock has been paying dividends for years
News
ASX Health Stocks: Botanix to get FDA approval by June; 4DMedical partners with global player, Philips
Health & Biotech
Bioxyne subsidiary unveils platform for transparent pricing in Australia’s B2B medical cannabis market
Health & Biotech
Check Up: Earnings season is almost here. Here’s how ASX biotech investors should read the 4C Report
Health & Biotech
Weed Week: Blow to cannabis as Thailand backpedals on weed law; and recent ASX pot stock winners
News